Month: May 2019

CSO Dr Roly Foulkes discusses importance of immune resetting at Biotrinity 2019

CSO Dr Roly Foulkes discusses importance of immune resetting at Biotrinity 2019 Stevenage, UK, 7 May 2019, Immune Regulation Limited (‘Immune Regulation’ or the ‘Company’) a biopharmaceutical company developing “first in class” immune-resetting therapies for asthma and other inflammatory diseases, announces that Dr. Roly Foulkes, Chief Scientific Officer, took part in a panel discussion titled… Read more »

Menu